Baxter Earns FDA Clearance for Hemodialysis System

Baxter has received FDA 510(k) marketing clearance for its Artificial Kidney 98 (AK 98) system, a portable device for hemodialysis.

The device is designed to prevent unnecessary halting of treatments due to brief pressure fluctuations that are usually caused by patient movement. It does this by self-clearing automatic pressure alarms that are already corrected.

The system is easily transported and features a customizable, app-like user interface that simplifies prescription management and treatment supervision.